921592-86-1

Basic information

• Product Name: 1-(5-AMINO-2-PYRIDINYL)-3-(R)-PYRROLIDINOL
• Synonyms: 1-(5-AMINO-2-PYRIDINYL)-3-(R)-PYRROLIDINOL;(R)-Pyrrolidinol&2,2-bispyrrolidine;(R)-Pyrrolidinol
• CAS NO: 921592-86-1
• Molecular Formula: C₉H₁₃N₃O
• Molecular Weight: 179.222
• Mol File: 921592-86-1.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(5-AMINO-2-PYRIDINYL)-3-(R)-PYRROLIDINOL(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(5-AMINO-2-PYRIDINYL)-3-(R)-PYRROLIDINOL(921592-86-1)
• EPA Substance Registry System: 1-(5-AMINO-2-PYRIDINYL)-3-(R)-PYRROLIDINOL(921592-86-1)

Safety Data

• Hazardous Substances Data: 921592-86-1(Hazardous Substances Data)

Usage

General Description

1-(5-amino-2-pyridinyl)-3-(R)-pyrrolidinol is a chemical compound that consists of a pyrrolidine ring attached to a pyridine ring with an amino group at the 5th position of the pyridine ring. It is a chiral compound, meaning it has a handedness or asymmetry in its molecular structure. This chemical has potential pharmaceutical applications, as it may have biological activity in the body due to its structure and interaction with biological systems. It is important to consider the chirality of 1-(5-amino-2-pyridinyl)-3-(R)-pyrrolidinol in pharmaceutical applications, as different enantiomers (mirror images) of chiral compounds can have different effects in the body. Understanding and controlling the chirality of this compound is important in drug development and medicinal chemistry.

Upstream product

• 4548-45-2 2-chloro-5-nitropyridine 
• 5418-51-9 5-nitro-2-hydroxypyridine 
• 921592-85-0 (R)-1-(5-nitropyridin-2-yl)pyrrolidin-3-ol 

Downstream Products

• 1419600-68-2 (R)-1-((1-(3-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl)methyl)-3-(6-(3-hydroxypyrrolidin-1-yl)pyridin-3-yl)urea 
• 1419604-07-1 (R)-phenyl 6-(3-hydroxypyrrolidin-1-yl)pyridin-3-ylcarbamate 

Relevant articles and documents

SUBSTITUTED HETEROAROMATIC PYRAZOLE-CONTAINING CARBOXAMIDE AND UREA DERIVATIVES AS VANILLOID RECEPTOR LIGANDS

The invention relates to substituted heteroaromatic pyrazole-containing carboxamide and urea derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

THERAPEUTIC AGENTS

Compounds of formula (I), processes for preparing such compounds, their use in the treatment of obesity, psychiatric disorders, cognitive disorders, memory disorders, schizophrenia, epilepsy, and related conditions, and neurological disorders such as dementia, multiple sclerosis, Parkinson's disease, Huntington's chorea and Alzheimer's disease and pain related disorders and to pharmaceutical compositions containing them.